Gradient Denervation Technologies is a startup based in France, most recent round Series A, 2 tracked investors.
Gradient Denervation Technologies is a company founded in 2024 headquartered in France. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Develops a minimally invasive, ultrasound-based catheter system to treat pulmonary hypertension in patients with heart failure by reducing sympathetic input into the pulmonary vasculature.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.